Search Result "sodium glucose co-transporter 2 inhibitors."
Sodium Glucose Co-Transporter 2 Inhibitors: Beyond Glucose Lowering
Journal: Current Drug Targets
Volume: 19 Issue: 9 Year: 2018 Page: 1045-1050
Author(s): Asli F. Ceylan,Sidney Y. Ren
A Review of Sodium Glucose Co-transporter 2 Inhibitors Canagliflozin, Dapagliflozin and Empagliflozin
Journal: Cardiovascular & Hematological Agents in Medicinal Chemistry
Volume: 13 Issue: 2 Year: 2015 Page: 105-112
Author(s): Saad Hussain Syed,Sucheta Gosavi,Waseem Shami,Marco Bustamante,Zul Farah,Muhammad Teleb,Aamer Abbas,Sarmad Said,Debabrata Mukherjee
Development of Sodium-Dependent Glucose Co-Transporter 2 Inhibitors as Potential Anti-Diabetic Therapeutics
Journal: Current Topics in Medicinal Chemistry
Volume: 11 Issue: 1 Year: 2011 Page: 1476-1512
Author(s): Low-Tone Ho, Suvarn S. Kulkarni, Jinq-Chyi Lee
Assessment of Knowledge and Perception of Sodium-Glucose Co-transporter 2 (SGLT-2) Inhibitors Prescription among Physicians in Saudi Arabia
Journal: Current Diabetes Reviews
Volume: 20 Issue: 4 Year: 2024 Page: 98-110
Author(s):
Recent Developments in Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitors as a Valuable Tool in the Treatment of Type 2 Diabetes Mellitus
Journal: Mini-Reviews in Medicinal Chemistry
Volume: 20 Issue: 3 Year: 2020 Page: 170-182
Author(s): Shubham Kumar,Gopal L. Khatik,Amit Mittal
Cognitive Benefits of Sodium-Glucose Co-Transporters-2 Inhibitorsin the Diabetic Milieu
Journal: Current Medicinal Chemistry
Volume: 31 Issue: 2 Year: 2024 Page: 138-151
Author(s):
Sodium-Glucose Co-Transporter 2 Inhibition in Diabetes Treatment: Current Evidence and Future Perspectives
Journal: Current Pharmaceutical Design
Volume: 20 Issue: 22 Year: 2014 Page: 3647-3656
Author(s): Evangelos C. Rizos,Moses S. Elisaf
Sodium Glucose Co-Transporter 2 (SGLT2) Inhibition with Canagliflozin in Type 2 Diabetes Mellitus
Journal: Cardiovascular & Hematological Agents in Medicinal Chemistry
Volume: 11 Issue: 3 Year: 2013 Page: 203-206
Author(s): Sarmad Said,German T. Hernandez
Sodium-Glucose Co-Transport Inhibitors: A New Therapeutic Option for Type 2 Diabetes Mellitus
Ebook: Frontiers in Clinical Drug Research-Diabetes and Obesity
Volume: 2 Year: 2016
Author(s): Athanasia K. Papazafiropoulou,Marina S. Kardara
Doi: 10.2174/9781681081854116020005
Empagliflozin-A Sodium Glucose Co-transporter-2 Inhibitor: Overview ofits Chemistry, Pharmacology, and Toxicology
Journal: Current Diabetes Reviews
Volume: 20 Issue: 10 Year: 2024 Page: 30-52
Author(s): Vaseem Ahamad Ansari